A randomised double blind trial to study the effectiveness and success rate of USG versus fluoroscopy(X-ray) guided caudal epidural steroid injections in adult patients with more than 3 months of radicular lower back pain

Efficacy and success rate of Ultrasound versus Fluoroscopy guided caudal epidural steroid injection in adult patients with chronic radicular lower back pain-a randomized double blind study - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069354

Enrollment

140

Registered

2024-06-21

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M472- Other spondylosis with radiculopathy

Interventions

Intervention1: Group A USG guided Caudal epidural Steroid (Triamcinolone acetate) injection : In Group A, under all aseptic precautions ultrasound imaging probe will be placed longitudinally on the ve

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adult patients 18 years of age 2.Patients with chronic radicular lower back pain (not responding to conservative treatment like physical therapy, muscle relaxant drugs, or non-steroidal anti-inflammatory drugs for 6 weeks) 3.Patients who are not candidates for surgical intervention.

Exclusion criteria

Exclusion criteria: Patients with Local or systemic infection. History of allergy to contrast. Coagulopathy or anticoagulant therapy. Progressive neurological deficit, motor weakness, sensory loss, cauda equina syndrome, bowel & bladder dysfunction. Low back pain with traumatic aetiology, chronic nonradicular lower back pain. Pregnant females. Patients who refused to participate in the study

Design outcomes

Primary

Measure	Time frame
To compare the pain relief at 1 month and procedure time with ultrasound versus fluoroscopy-guided caudal epidural steroid injections.Timepoint: 1 month	—

Secondary

Measure	Time frame
The following outcome measures will be measured A) Pain relief in patients will be measured using NRS B) Improvement in disability index in patients will be measured using the ODI C) For measuring improvement in quality of life will be using the SF-12 score D) For measuring patient satisfaction will be using the Likert scale E) Adverse reactions if any e.g., facial flushing, infection etc. will be noted and reportedTimepoint: At 2 weeks, 1 month and 3 months	—

Measure

Time frame

The following outcome measures will be measured A) Pain relief in patients will be measured using NRS B) Improvement in disability index in patients will be measured using the ODI C) For measuring improvement in quality of life will be using the SF-12 score D) For measuring patient satisfaction will be using the Likert scale E) Adverse reactions if any e.g., facial flushing, infection etc. will be noted and reportedTimepoint: At 2 weeks, 1 month and 3 months

—

Countries

India

Contacts

Public ContactDrMayank Gupta

All India Institute of Medical Sciences, Bathinda, Punjab

drm_gupta@yahoo.co.in8077754166

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026